GCG and Hypoglycemia: The latest American Diabetes Association guideline has recently revised the recommendations for choosing antidiabetic agents and suggests that a GLP-1 agonist, an injectable medication, is preferred over basal insulin to reduce the risk of hypoglycemia and weight gain13.